|
MRE11A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63224989080391E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.00290952898786E-12 |
| Normal-vs-Stage2 |
1.60230000378903E-08 |
| Normal-vs-Stage3 |
2.21179963233453E-10 |
| Normal-vs-Stage4 |
1.860099962947E-09 |
| Stage1-vs-Stage2 |
3.005200E-01 |
| Stage1-vs-Stage3 |
4.320000E-01 |
| Stage1-vs-Stage4 |
1.718230E-01 |
| Stage2-vs-Stage3 |
6.770000E-01 |
| Stage2-vs-Stage4 |
7.983600E-01 |
| Stage3-vs-Stage4 |
4.780600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.73683331342545E-13 |
| Normal-vs-AfricanAmerican |
3.431500E-04 |
| Normal-vs-Asian |
2.33780000025163E-07 |
| Caucasian-vs-AfricanAmerican |
5.763200E-01 |
| Caucasian-vs-Asian |
8.669000E-01 |
| AfricanAmerican-vs-Asian |
5.354600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.35619984529012E-10 |
| Normal-vs-Female |
2.2234436514168E-12 |
| Male-vs-Female |
2.219600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.19020049161156E-10 |
| Normal-vs-Age(41-60Yrs) |
4.52782256132878E-12 |
| Normal-vs-Age(61-80Yrs) |
2.10139683431976E-11 |
| Normal-vs-Age(81-100Yrs) |
1.122270E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.806000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.280210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.149400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.198600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.580000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.470800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.670820E-01 |
| Classical-VS-Follicular |
4.579200E-04 |
| Classical-VS-Other |
2.007000E-01 |
| Classical-VS-Normal |
1.64689999970768E-07 |
| Tall-VS-Follicular |
4.115000E-01 |
| Tall-VS-Other |
5.696000E-01 |
| Tall-VS-Normal |
1.2650000003056E-07 |
| Follicular-VS-Other |
9.377000E-01 |
| Follicular-VS-Normal |
7.46702699672142E-12 |
| Other-VS-Normal |
2.422800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.37587727269783E-14 |
| Normal-vs-N1 |
2.97219999723097E-08 |
| N0-vs-N1 |
9.927200E-01 |
|
|
